RTA
Retatrutide is an investigational multi-receptor peptide agonist that interacts with GLP-1, GIP, and glucagon receptors, aiming to study combined incretin–glucagon signaling mechanisms.
- The description claims that Retatrutide engages three receptor systems involved in glucose regulation, lipid metabolism, energy balance, and gastrointestinal signaling.
Specifications
- MG | ML
- 5mg - 3ML, 10mg - 3ML, 15mg - 3ML, 20mg - 3ML, 30mg - 3ML, 40mg - 3ML, 50mg - 3ML, 60mg - 3ML, 60mg - 10ML, 100mg - 10ML
Variants (10)
- 5mg - 3ML — 160.00 USD — In stock
- 10mg - 3ML — 195.00 USD — In stock
- 15mg - 3ML — 270.00 USD — In stock
- 20mg - 3ML — 285.00 USD — In stock
- 30mg - 3ML — 375.00 USD — In stock
- 40mg - 3ML — 480.00 USD — In stock
- 50mg - 3ML — 450.00 USD — In stock
- 60mg - 3ML — 520.00 USD — In stock
- 60mg - 10ML — 540.00 USD — In stock
- 100mg - 10ML — 700.00 USD — In stock
AI Readiness
Good foundation, but some important product data is still missing.
76%